secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amylyx Pharmaceuticals, Inc. (AMLX)
CIK:        0001658551
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001193125-24-156050
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amylyx shareholders elect Cohen, Quimi as directors; ratify Deloitte
--------------------------------------------------------------------

- Joshua Cohen and Daphne Quimi elected as Class III directors with ~32.6M and ~32.5M votes for, respectively.
- Deloitte & Touche LLP ratified as independent auditor for FY2024 with 52,023,591 votes for, 162,947 against.
- Non-binding advisory vote on NEO compensation approved: 41,211,831 for, 2,708,178 against, 38,594 abstain.
- Shareholders chose 'One Year' as preferred frequency for future say-on-pay votes (38,275,989 for one year).
- Broker non-votes of 8,341,537 on director elections and executive compensation proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658551/000119312524156050/0001193125-24-156050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658551/000119312524156050/d844544d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-156050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer